Genetic alteration of stemness factors and p53 in mouse forestomach by chemical carcinogen-induced carcinogenesis

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1216-1220

  Yamamoto, Kazuyoshi ^a   Ishii, Hideshi ^a   Moon, Jeong Ho ^a   Haraguchi, Naotsugu ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinogenesis; Forestomach; Squamous cell carcinoma; Stemness factors

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; N BENZYL N METHYLNITROSAMINE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EARLY CANCER; EPITHELIUM CELL; FORESTOMACH; GENE MUTATION; HISTOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOGENESIS; TUMOR GROWTH;

EID: 84859467540     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.642     Document Type: Article

References (24)

1. Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872, 2007.
3. Yamanaka S: Elite and stochastic models for induced pluripotent stem cell generation. Nature 460: 49-52, 2009.
4. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507, 2008.
5. Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L, Fend F, Perner S, Bareiss PM and Staebler A: Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11: 42, 2011.
6. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005.
7. Tetreault MP, Wang ML, Yang Y, Travis J, Yu QC, Klein-Szanto AJ and Katz JP: Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology 139: 2124-2134, 2010.
8. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, and Liu Z: MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 285: 7986-7994, 2010.
9. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ and Tang DG: Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005, 2009.
10. Glinsky GV: 'Stemness' genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol 26: 2846-2853, 2008.
11. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS and Wu CW: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444, 2010.
12. Hickman ES, Moroni MC and Helin K: The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 12: 60-66, 2002.
13. Pan G and Thomson JA: Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17: 42-49, 2007.
14. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E and Xu Y: p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7: 165-171, 2005.
15. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J and Bartek J: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870, 2005.
16. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C and Halazonetis TD: Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913, 2005.
17. Rich AM, Kerdpon D and Reade PC: p53 expression in oral precancer and cancer. Aust Dent J 44: 103-105, 1999.
18. Pontén J: Cell biology of precancer. Eur J Cancer 37: S97-S113, 2001.
19. Ozols R: Esophageal cancer. Curr Problems Cancer 18: 191-246, 1994.
20. Fong LYY, Ishii H, Nguyen VT, Vecchione A, Farber JT, Croce CM and Huebner K: p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. Cancer Res 63: 186-195, 2003.
21. Carlton PS, Kresty LA, Siglin JC, Morse MA, Lu J, Morgan C and Stoner GD: Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 22: 441-446, 2001.
22. Dumon KR, Ishii H, Fong LYY, Zanesi N, Fidanza V, Mancini R, Vecchione A, Baffa R, Trapasso F, During MJ, Huebner K and Croce CM: FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci USA 98: 3346-3351, 2001.
23. Coia LR: The esophagus. In: Moss' Radiation Oncology: Rationale, Techniques, Results. Cox J (ed.) Mosby-Year Book, St. Louis, p409, 1994.
24. Blot WJ: Esophageal cancer trends and risk factors. Semin Oncol 21: 403-410, 1994.